TGTX - TG Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TGTX is currently covered by 8 analysts with an average price target of $45.17. This is a potential upside of $10.75 (31.23%) from yesterday's end of day stock price of $34.42.

TG Therapeutics's activity chart (see below) currently has 61 price targets and 84 ratings on display. The stock rating distribution of TGTX is 84.21% BUY, 5.26% SELL and 10.53% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.34% with an average time for these price targets to be met of 287.75 days.

Highest price target for TGTX is $55, Lowest price target is $22, average price target is $29.67.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 15-Jan-2025. First documented stock forecast 22-Jul-2014.

Currently out of the existing stock ratings of TGTX, 32 are a BUY (84.21%), 2 are a SELL (5.26%), 4 are a HOLD (10.53%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$55

$24.91 (82.78%)

$55

1 months 17 days ago
(15-Jan-2025)

9/19 (47.37%)

$24.82 (82.24%)

243

Buy

$43

$12.91 (42.90%)

$25

3 months 7 days ago
(25-Nov-2024)

7/8 (87.5%)

$8.39 (24.24%)

198

Hold

$22

$-8.09 (-26.89%)

$20

3 months 27 days ago
(05-Nov-2024)

5/8 (62.5%)

$-3.86 (-14.93%)

147

Buy

$34

$3.91 (12.99%)

$29

6 months 25 days ago
(07-Aug-2024)

12/14 (85.71%)

$14.01 (70.09%)

245

Buy

$19

1 years 8 months 6 days ago
(26-Jun-2023)

3/4 (75%)

$11.74 (161.71%)

176

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TGTX (TG Therapeutics) average time for price targets to be met?

On average it took 287.75 days on average for the stock forecasts to be realized with a an average price target met ratio 67.34

Which analyst has the current highest performing score on TGTX (TG Therapeutics) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on TGTX (TG Therapeutics)?

Alethia Young works at CANTOR FITZGERALD and has 5 price targets and 5 ratings on TGTX

Which analyst is the currently most bullish on TGTX (TG Therapeutics)?

Matthew Kaplan with highest potential upside - $54.89

Which analyst is the currently most reserved on TGTX (TG Therapeutics)?

Alec Stranahan with lowest potential downside - -$24.71

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?